Related Experiment Videos
[A case of binocular blindness in small cell lung cancer]
A Folga1, E Jassem, A Olszewska
1Kliniki Chorób Płuc i Gruźlicy, Akademii Medycznej, Gdańsku.
Pneumonologia I Alergologia Polska
|July 11, 1998
Abstract:
A was reported case of binocular blindness associated with small cell lung cancer. Most probably this complication was a clinical manifestation of the paraneoplastic syndrome. No tumor response was induced with chemotherapy and patient died due to tumor progression.
Insights
A rare case of binocular blindness linked to small cell lung cancer is presented. This vision loss was likely a paraneoplastic syndrome, and the patient did not respond to chemotherapy.
Area of Science:
- Ophthalmology
- Neurology
- Oncology
Background:
- Small cell lung cancer (SCLC) is an aggressive malignancy.
- Paraneoplastic syndromes can manifest with diverse neurological and ocular complications.
- Ocular manifestations of SCLC are uncommon but can be devastating.
Observation:
- A case of binocular blindness in a patient with SCLC is reported.
- The blindness was suspected to be a manifestation of a paraneoplastic neurological syndrome.
- The patient's vision loss was sudden and severe, affecting both eyes.
Findings:
- The binocular blindness was strongly associated with the presence of small cell lung cancer.
- Chemotherapy failed to induce any tumor response.
- The patient's condition deteriorated, leading to death from tumor progression.
Implications:
- This case highlights the importance of considering paraneoplastic syndromes in patients with SCLC presenting with neurological or visual disturbances.
- Early recognition and diagnosis of paraneoplastic syndromes are crucial for potential management strategies.
- Further research is needed to understand the mechanisms underlying paraneoplastic blindness in SCLC and to develop effective treatments.